Home  /  Resource Library  /  Pegfilgrastim Use and Risk of Bleomycin Induced Pulmonary Toxicity in Hodgkin Lymphoma

Pegfilgrastim Use and Risk of Bleomycin Induced Pulmonary Toxicity in Hodgkin Lymphoma

In this retrospective study, pegfilgrastim use with ABVD in HL was associated with a low (2.9%) risk of BPT.